Abbott Laboratories
ABT · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $1,644 | $1,779 | $1,325 | $9,229 |
| Dep. & Amort. | $791 | $777 | $756 | $807 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $120 | $142 | $289 | $111 |
| Change in WC | $11 | -$407 | -$517 | -$8,391 |
| Other Non-Cash | $221 | -$244 | -$436 | $1,112 |
| Operating Cash Flow | $2,787 | $2,047 | $1,417 | $2,868 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$496 | -$502 | -$484 | -$720 |
| Net Acquisitions | -$55 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $94 | -$80 | $14 | -$146 |
| Investing Cash Flow | -$457 | -$582 | -$470 | -$866 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$493 | -$15 | -$1,036 | -$613 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$305 | -$6 | -$280 | -$315 |
| Dividends Paid | -$1,031 | -$1,029 | -$1,026 | -$958 |
| Other Fin. Act. | $69 | -$47 | $287 | $25 |
| Financing Cash Flow | -$1,760 | -$1,097 | -$2,055 | -$1,861 |
| Forex Effect | -$10 | $51 | $24 | -$83 |
| Net Chg. in Cash | $560 | $419 | -$1,084 | $58 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $6,951 | $6,532 | $7,616 | $7,558 |
| End Cash | $7,511 | $6,951 | $6,532 | $7,616 |
| Free Cash Flow | $2,291 | $1,545 | $933 | $2,148 |